These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37704072)

  • 21. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
    Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
    Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy.
    Cacciola R; Gentilini Cacciola E; Vecchio V; Cacciola E
    J Thromb Thrombolysis; 2022 Feb; 53(2):282-290. PubMed ID: 34687400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
    Hartung TJ; Neumann C; Bahmer T; Chaplinskaya-Sobol I; Endres M; Geritz J; Haeusler KG; Heuschmann PU; Hildesheim H; Hinz A; Hopff S; Horn A; Krawczak M; Krist L; Kudelka J; Lieb W; Maetzler C; Mehnert-Theuerkauf A; Montellano FA; Morbach C; Schmidt S; Schreiber S; Steigerwald F; Störk S; Maetzler W; Finke C
    EClinicalMedicine; 2022 Nov; 53():101651. PubMed ID: 36133318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach.
    Silva CC; Bichara CNC; Carneiro FRO; Palacios VRDCM; Berg AVSVD; Quaresma JAS; Magno Falcão LF
    Rev Med Virol; 2022 Nov; 32(6):e2355. PubMed ID: 35416359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
    Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
    Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS.
    Morrow AK; Malone LA; Kokorelis C; Petracek LS; Eastin EF; Lobner KL; Neuendorff L; Rowe PC
    Curr Pediatr Rep; 2022; 10(2):31-44. PubMed ID: 35287333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Incidence of Long-Term Fatigue in Patients Who Achieved Remission From COVID-19 at King Abdulaziz Medical City.
    Alotibi WM; Alzeer Z; Alfarhan IF; Alharbi AD; Alhaqbani FA; Almutairi AS; Alhazmi TM
    Cureus; 2023 Jan; 15(1):e33869. PubMed ID: 36819348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
    Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
    J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
    Six I; Guillaume N; Jacob V; Mentaverri R; Kamel S; Boullier A; Slama M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors.
    Brunner-Ziegler S; Bäuerle M; Brühl P; Kornek G; Parschalk B; Savic R; Schnetzinger M; Spath T; Straßl RP; Handisurya A; Thalhammer F
    J Infect Public Health; 2023 Apr; 16(4):596-602. PubMed ID: 36842195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.
    Terlizzi K; Kutscher E; Yoncheva Y
    J Am Board Fam Med; 2021; 34(5):1014-1016. PubMed ID: 34535527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Long-COVID: A Review of the Definition, Epidemiology, Presentation, and Pathophysiology.
    Yonts A Brugler
    Pediatr Ann; 2022 Nov; 51(11):e416-e420. PubMed ID: 36343180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
    Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.